Anxiety and epilepsy: what neurologists and epileptologists should know (Q38197945)

30 August 2017

1 reference

title

Anxiety and epilepsy: what neurologists and epileptologists should know (English)

1 reference

30 August 2017

Heidi M Munger Clary

1

1 reference

30 August 2017

1 May 2014

1 reference

Current Neurology and Neuroscience Reports

30 August 2017

1 reference

30 August 2017

14

1 reference

30 August 2017

5

1 reference

30 August 2017

445

1 reference

https://scigraph.springernature.com/pub.10.1007/s11910-014-0445-9

30 August 2017

0 references

cites work

Psychiatric issues in epilepsy: the complex relation of mood, anxiety disorders, and epilepsy

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0445-9

Anxiety disorders in epilepsy: the forgotten psychiatric comorbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0445-9

Anxiety in patients with epilepsy: systematic review and suggestions for clinical management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0445-9

Epilepsy and psychiatric comorbidity: a nationally representative population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0445-9

Psychiatric comorbidity and suicidal behavior in epilepsy: a community-based case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0445-9

The psychiatric comorbidity of epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0445-9

Prevalence of anxiety disorders in patients with refractory focal epilepsy--a prospective clinic based survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0445-9

A community study of the presence of anxiety disorder in people with epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0445-9

Changes in depression and anxiety after resective surgery for epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0445-9

A national profile of childhood epilepsy and seizure disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0445-9

Psychiatric comorbidity in children with new onset epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0445-9

Depression and anxiety disorders in pediatric epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0445-9

Prevalence of and risk factors for anxiety and depressive disorders in Nigerian adolescents with epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0445-9

Symptoms of anxiety and depression among adolescents with seizures in Irbid, Northern Jordan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0445-9

Differential effects of seizure control and affective symptoms on quality of life in people with epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0445-9

Anxiety disorders, subsyndromic depressive episodes, and major depressive episodes: do they differ on their impact on the quality of life of patients with epilepsy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0445-9

Predictors of health-related quality of life and costs in adults with epilepsy: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0445-9

Factors affecting the quality of life in patients with epilepsy in Seoul, South Korea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0445-9

Association of subjective anxiety, depression, and sleep disturbance with quality-of-life ratings in adults with epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0445-9

The impact of depression and anxiety disorder symptoms on the health-related quality of life of children and adolescents with epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0445-9

Severity of anxiety and depression are related to a higher perception of adverse effects of antiepileptic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0445-9

Depressive and anxiety disorders in epilepsy: do they differ in their potential to worsen common antiepileptic drug-related adverse events?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0445-9

Cognitive complaints after a first seizure in adulthood: Influence of psychological adjustment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0445-9

Subjective memory and mood of Hong Kong Chinese adults with epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0445-9

Characteristics of people with epilepsy who attend emergency departments: prospective study of metropolitan hospital attendees

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0445-9

Depression and anxiety in a community sample with epilepsy in Brazil

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0445-9

Rates of DSM-IV mood, anxiety disorders, and suicidality in Australian adult epilepsy outpatients: a comparison of well-controlled versus refractory epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0445-9

Prospective study of risk factors for suicidal behavior in individuals with anxiety disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0445-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0445-9

Temporal trends in new exposure to antiepileptic drug monotherapy and suicide-related behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0445-9

Neurocognitive and psychological profiles of adult patients with epilepsy in Hong Kong.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0445-9

Psychiatric comorbidity in adult patients with idiopathic generalized epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0445-9

Neuropsychiatric profiles of patients with juvenile myoclonic epilepsy treated with valproate or topiramate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0445-9

The psychological impact of a newly diagnosed seizure: losing and restoring perceived control.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0445-9

Neuropsychiatric symptomatology predicts seizure recurrence in newly treated patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0445-9

Predictors of pharmacoresistant epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0445-9

A lifetime psychiatric history predicts a worse seizure outcome following temporal lobectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0445-9

Predictors of psychiatric and seizure outcome following temporal lobe epilepsy surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0445-9

Major depressive disorder as a predictor of a worse seizure outcome one year after surgery in patients with temporal lobe epilepsy and mesial temporal sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0445-9

Do psychiatric comorbidities predict postoperative seizure outcome in temporal lobe epilepsy surgery?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0445-9

Are psychiatric disorders independent risk factors for new-onset epilepsy in older individuals?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0445-9

Anxiety and depressive symptoms in children presenting with a first seizure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0445-9

Hospitalization for psychiatric disorders before and after onset of unprovoked seizures/epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0445-9

Epilepsy, suicidality, and psychiatric disorders: a bidirectional association.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0445-9

Familial clustering of epilepsy and behavioral disorders: evidence for a shared genetic basis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0445-9

Serotonin gene polymorphisms and psychiatry comorbidities in temporal lobe epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0445-9

Psychiatric comorbidities and epilepsy: is it the old story of the chicken and the egg?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0445-9

Limbic reductions of 5-HT1A receptor binding in human temporal lobe epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0445-9

Reduced serotonin type 1A receptor binding in panic disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0445-9

Serotonergic abnormalities in the central nervous system of seizure-naive genetically epilepsy-prone rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0445-9

Noradrenergic abnormalities in the genetically epilepsy-prone rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0445-9

Decreased brain GABA(A)-benzodiazepine receptor binding in panic disorder: preliminary results from a quantitative PET study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0445-9

Relationship between atrophy of the amygdala and ictal fear in temporal lobe epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0445-9

Structural evidence for involvement of a left amygdala-orbitofrontal network in subclinical anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0445-9

Seizure occurrence: precipitants and prediction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0445-9

21 January 2018

Epilepsy and Anxiety.

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0445-9

Prevalence and clinical characteristics of postictal psychiatric symptoms in partial epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0445-9

Prevalence of psychopathology in childhood epilepsy: categorical and dimensional measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0445-9

Alexithymia and posttraumatic stress disorder following epileptic seizure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0445-9

The impact of self-efficacy, alexithymia and multiple traumas on posttraumatic stress disorder and psychiatric co-morbidity following epileptic seizures: a moderated mediation analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0445-9

A psychosocial view of anxiety and depression in epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0445-9

Psychosocial predictors of depression and anxiety in patients with epilepsy: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0445-9

End-of-dose emergent psychopathology in ambulatory patients with epilepsy on stable-dose lamotrigine monotherapy: a case series of six patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0445-9

Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0445-9

The treatment of depressive disorders in epilepsy: what all neurologists should know

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0445-9

Group cognitive-behavioral therapy for patients with epilepsy and comorbid depression and anxiety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0445-9

Cognitive-behavioral group treatment program for adults with epilepsy in Hong Kong

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0445-9

Computer-assisted cognitive behavioral therapy for children with epilepsy and anxiety: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0445-9

An open-label, add-on study of pregabalin in patients with partial seizures: a multicenter trial in Greece.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0445-9

Efficacy and safety of pregabalin in refractory focal epilepsy with and without comorbid anxiety disorders - results of an open-label, parallel group, investigator-initiated, proof-of-concept study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0445-9

Long-term efficacy of pregabalin in generalized anxiety disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0445-9

Treatment of anxiety disorders in epilepsy: an evidence-based approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0445-9

The use of psychotropic drugs in epilepsy: what every neurologist should know

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0445-9

Clinically significant drug interactions with newer antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11910-014-0445-9

The Amygdala and Temporal Lobe Simple Partial Seizures: A Prospective and Quantitative MRI Study

21 January 2018

1 reference

12 December 2020

Fear of seizures: an investigation and treatment

1 reference

12 December 2020

Refractory epilepsy: an evaluation of psychological methods in outpatient management

1 reference

12 December 2020

The clinical course of epilepsy and its psychosocial correlates: findings from a U.K. Community study

1 reference

12 December 2020

Factors associated with generic and disease-specific quality of life in epilepsy

1 reference

12 December 2020

Comorbidity of ictal fear and panic disorder

1 reference

12 December 2020

Obsessive–compulsive symptoms in patients with temporal lobe epilepsy

1 reference

12 December 2020

Epilepsy and obsessive-compulsive disorder.

1 reference

12 December 2020

The relative impact of anxiety, depression, and clinical seizure features on health-related quality of life in epilepsy

1 reference

12 December 2020

Prevalence of Self-Reported Epilepsy or Seizure Disorder and Its Associations with Self-Reported Depression and Anxiety: Results from the 2004 Healthstyles Survey

1 reference

12 December 2020

Comorbidities of epilepsy: results from the Epilepsy Comorbidities and Health (EPIC) survey

1 reference

12 December 2020

Panic attack semiology in right temporal lobe epilepsy.

1 reference

12 December 2020

Epilepsy and anxiety: epidemiology, classification, aetiology, and treatment.

1 reference

12 December 2020

Utilization of care among drug resistant epilepsy patients with symptoms of anxiety and depression.

1 reference

12 December 2020

The Assessment and Treatment of Concerns and Anxiety in Patients Undergoing Presurgical Monitoring for Epilepsy

1 reference

12 December 2020

Effect of pregabalin add-on treatment on seizure control, quality of life, and anxiety in patients with brain tumour-related epilepsy: a pilot study.

1 reference

12 December 2020

The Liverpool Adverse Events Profile: relation to AED use and mood

1 reference

12 December 2020

Mood change preceding epileptic seizures.

1 reference

12 December 2020

Prevalence of Psychopathology in Dutch Epilepsy Inpatients: A Comparative Study

1 reference

12 December 2020

10.1007/S11910-014-0445-9

Identifiers

DOI

1 reference

PubMed ID

24652453

Dimensions Publication ID

30 August 2017

0 references

1 reference

PubMed ID

24652453